BioMarin is a biotech company focusing on the delivery of first-to-market therapies for patients with rare genetic diseases.
Tag Archives: Pompe Disease
Oxyrane – enzyme replacement therapies
Oxyrane develops Enzyme Replacement Therapies (ERTs) for the treatment of lysosomal storage diseases (LSDs) using a proprietary engineered yeast expression platform based on Yarrowia lipolytica.
